ALPHAWIN and syd Life AI have partnered to bring a cutting-edge life quality platform to help 3.5 million Filipinos.
AlphaWIN (Alpha Whisperers International Network) is internationally recognized for its expertise in global partnerships, systemic innovation, and transformative ventures. syd Life AI is a world leader in artificial intelligence (AI)-driven risk prediction and prevention solutions. Their partnership agreement seeks to deliver syd Life AI’s technology and life quality solutions to more than 3.5 million lives in the Philippines over the next five years.
The Philippine Institute of Development Studies warns that without action, health cases could double by 2040. An AXA study also reveals that 87 percent of professionals in the country experience work-related mental health issues. Compounding these issues is low health literacy that limits individuals in making informed health decisions.
Thus, the new collaboration is a major step in addressing the country’s growing health challenges, particularly preventable noncommunicable diseases (NCDs) and mental health concerns. The AI platform’s advanced capabilities ease the burden of NCDs on governments, insurers, organizations, health care systems, and employers. By mitigating health risks, lowering costs, and improving long-term health outcomes, the partnership between AlphaWIN and syd Life AI is expected to drive meaningful, lasting change.
“The partnership will leverage evidence-based and validated AI technology to help shape a brighter future for millions of people, both current and future generations,” said Lorena Puica, chief executive and founder of syd Life AI.
AI is shaping the future of AI-powered preventive health and life quality transformation. By leveraging AI-driven insights, syd provides personalized, proactive recommendations that allow members to take informed action to improve overall health. On the other hand, organizations gain real-time analytics to drive better health and productivity outcomes, with proven returns of up to 25 times ROI.
A highly successful clinical trial with the NHS (National Health Service) in the UK demonstrated a 12 to 16 percent decrease in clinical levels of stress, anxiety, and depression in only three months. A 48 percent reduction in stress, anxiety, and depression was seen in 12 months, with 98 percent experiencing improvements in life quality and up to a 40 percent decrease in the risk of developing key NCDs.
The NHS study further validated syd AI’s effectiveness in significantly lowering the risk of noncommunicable diseases. Significant reductions were likewise observed in mental health conditions, in cardiovascular disease, in type 2 diabetes, and in musculoskeletal disorders. For organizations, syd has delivered a 23 percent increase in productivity, a 15 percent boost in retention, and up to 25 times ROI.
“By combining their global networks with syd’s cutting-edge AI, the collaboration is catalyzing a new paradigm for health and life quality improvement in the country,” said Janet C. Salazar, chief executive and founder of the AlphaWIN Group.